Moolec Science SA

As of August 20, 2025, Moolec Science SA is in a bearish trend with weak momentum, underperforming the S&P 500 by -85.0% year-to-date, despite some bullish signals from the weekly RSI.

As of December 14, 2023, Moolec Science SA is considered risky and overvalued due to troubling financial ratios, including a Price to Book Value of 9.90 and a ROCE of -45.51%, which indicate significant inefficiencies and losses compared to its peers, while its stock has underperformed the S&P 500 with a 1Y return of -37.32%.

As of April 18, 2024, Moolec Science SA shows a mildly bearish trend due to daily moving averages, despite some mildly bullish signals from the weekly MACD and KST, leading to a cautious outlook overall.

Moolec Science SA is a micro-cap company in the miscellaneous industry, reporting net sales of $3 million and a net loss of $2 million as of December 2024. It has a market cap of $27.47 million and key metrics indicate a high debt-to-equity ratio and negative return on equity.

As of Jun 18, Moolec Science SA has a market capitalization of 27.47 million, with net sales of 7.83 million and a net profit of -8.29 million over the latest four quarters. As of Jun 24, shareholder's funds are 6.82 million and total assets are 34.79 million.